LETTER TO EDITOR
Year : 2009 | Volume
: 52 | Issue : 2 | Page : 292-
Severe ABO hemolytic disease of newborn with a positive direct antiglobulin test
Neelam Marwaha1, Hari Krishan Dhawan2, Beenu Thakral1, Ravneet Kaur2, Sabita Basu2, Veena Parmar3,
1 Department of Transfusion Medicine, PGIMER, Chandigarh, India
2 Department of Immunohaematology and Blood Transfusion, Govt. Medical College and Hospital, Chandigarh, India
3 Department of Paediatrics, Govt. Medical College and Hospital, Chandigarh, India
Department of Transfusion Medicine, PGIMER, Chandigarh - 160 012
|How to cite this article:|
Marwaha N, Dhawan HK, Thakral B, Kaur R, Basu S, Parmar V. Severe ABO hemolytic disease of newborn with a positive direct antiglobulin test.Indian J Pathol Microbiol 2009;52:292-292
|How to cite this URL:|
Marwaha N, Dhawan HK, Thakral B, Kaur R, Basu S, Parmar V. Severe ABO hemolytic disease of newborn with a positive direct antiglobulin test. Indian J Pathol Microbiol [serial online] 2009 [cited 2023 May 29 ];52:292-292
Available from: https://www.ijpmonline.org/text.asp?2009/52/2/292/48958
A male infant weighing 2.75kg was born by normal vaginal delivery at 38 weeks to an O Rh (D)-positive multigravida (gravida 3) mother after an uneventful pregnancy. At 36 h of life, the baby was noticed to be deeply icteric. Investigations revealed total serum bilirubin (TSB) of 20.0mg/dL, packed cell volume (PCV) of 34% with peripheral blood smear showing mild anisopoikilocytosis with polychromasia. ABO Rh (D) typing and a direct antiglobulin test (DAT) were performed on the patient sample. The infant was A 1 Rh (D) positive with DAT positive using polyspecific antihuman globulin (anti-IgG + anti-C 3 d). With monospecific antihuman globulin, only anti-IgG was found to be positive and anti-C 3 d was negative. Possibility of ABO hemolytic disease of newborn (HDN) with or without presence of other irregular antibodies was considered. Newborn, maternal and paternal blood groups were found to be A 1 Rh (D) positive, O Rh (D) positive and A 1 Rh (D) positive, respectively. Antibody screen using a 0.8% commercial three-cell panel (Diacell, Switzerland) by column agglutination technology was negative on maternal serum, infant's serum and eluate from the newborn's red cell. Newborn's serum and eluate from its red blood cells demonstrated presence of anti-A, which confirmed the diagnosis of ABO HDN. Maternal serum had high titer anti-A (IgG titer 1:2048) after dithiothretiol treatment by the tube technique. TSB of the infant increased to 21.0 mg/dL and he received a double volume exchange transfusion (DVET) using O Rh (D)-positive peripheral red blood cells (PRBC) along with AB blood group plasma followed by intravenous immunoglobulin (IVIg) at a dose of 1mg/kg body weight. After DVET and IVIg, the TSB dropped to 10.1mg/dL. [Figure 1] shows the course of post-natal stay of the child in the neonatal nursery. The child was under phototherapy till post-natal day 6 of life and was discharged on day 7 of life.
ABO incompatibility between the mother and the baby occurs in 15-20% of all pregnancies, which produces HDN in 10% of these cases.  As compared with the other ABO blood groups that have predominantly IgM antibodies, 40-93% of the group O mothers also have IgG anti-A and anti-B antibodies.  Factors known to affect the severity of ABO HDN include not only the quantity of maternal anti-A or anti-B that cross the placenta but also the Ig subclass as each has different biological properties affecting their lytic potential.  Our case highlights the fact that ABO incompatibility is not always a benign condition and should be considered in all babies who have hemolysis and whose mothers are group O, even in the presence of a negative DAT. Asians and blacks have a higher prevalence of DAT-positive ABO HDN than Caucasians.  In ABO HDN, newborns with A and, especially, A 1 blood groups have more severe disease as compared with B or A 2 blood group newborns.  In the present case, the infant was typed as A 1 positive with anti-A 1 lectin.
It is therefore important to recognize that ABO HDN, although an often mild disease, can have an unexpectedly severe course and we need to be conscious of this so that appropriate intervention can be employed promptly to prevent serious complications.
|1||Usha KK, Sulochana PV. Detection of high risk pregnancies with relation to ABO hemolytic disease of newborn. Indian J Pediatr 1998;65:863-5.|
|2||Ziprin JH, Payne E, Hamidi L, Roberts I, Regan F. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia. Transfus Med 2005;15:57-60.|
|3||Peevy KJ, Wiseman HJ. ABO hemolytic disease of the newborn: �Evaluation of management and identification of racial and antigenic factors. Pediatrics 1978;61:475-8.|
|4||Toy PT, Reid ME, Papenfus L, Yeap HH, Black D. Prevalence of ABO maternal-infant incompatibility in Asians, Blacks, Hispanics and �Caucasians. Vox Sang 1988;54:181-3.|
|5||Goraya J, Basu S, Sodhi P, Mehta S. Unusually severe ABO hemolytic disease of newborn. Indian J Pediatrics 2001;68:285-6.|